immusmol是由Alban Bessede博士于2012年在法國(guó)創(chuàng)立，ImmuSmol設(shè)計(jì)和開(kāi)發(fā)了能夠靶向900道爾頓以下低分子量小分子的抗體，例如氨基酸代謝物、脂質(zhì)、糖類、毒素、類固醇等。小分子抗體與現(xiàn)有的基于抗體的技術(shù)wan全兼容，在研究、診斷和治療應(yīng)用中開(kāi)辟了一系列全新的可能性。immusmol團(tuán)隊(duì)由大約20名不同背景和應(yīng)用領(lǐng)域的人才組成，將他們的專業(yè)知識(shí)和經(jīng)驗(yàn)帶到公司。immusmol旨在成為小分子抗體開(kāi)發(fā)的shou選。

immusmol提供經(jīng)過(guò)驗(yàn)證的小分子抗體和ELISA試劑盒?？贵w通過(guò)ELISA的特異性和親和力進(jìn)行選擇，能夠快速、可靠地檢測(cè)和/或定量各種類型的生物材料中的小分子，包括細(xì)胞和裂解物、組織和勻漿、培養(yǎng)上清液、血漿和血清樣品。

Immusmol針對(duì)靶標(biāo)領(lǐng)域：

使用immusmol產(chǎn)品發(fā)表的部分文獻(xiàn)：

1. Lalitsuradej et al., 2022. Correlation between nicotine dependence and inflammatory biomarkers in Thai smokers: eight weeks of synbiotic intervention. IAES International Journal of Artificial Intelligence (IJ-AI), 11 (4): 1414-1425.

2. Park et al., 2022. Priming Mesenchymal Stem/Stromal Cells with a Combination of a Low Dose of IFN- and Bor_tezomib Results in Potent Suppression of Pathogenic Th17 Immunity Through the IDO1-AHR Axis. Stem Cells, 41 (1): 64-76.

3. Silvano et al., 2022. Tryptophan degradation enzymes and Angiotensin (1?7) expression in human placenta. Journal of Reproductive Immunology, 153: 103692.

4. Struckmeier et al., 2022. IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma. Journal of Cancer Reasearch & Clinical Oncology, 149: 3623-3635.

5. Gargaro et al., 2022. Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication. Immunity, 55 (6): 1032-1050.

6. Uefune et al., 2022. Dopamine Negatively Regulates Insulin Secretion Through Activation of D1-D2 Receptor Heteromer. Diabetes, 71 (9): 1946-1961.

7. Siska et al., 2022. Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo. eBioMedicine, 74: 103734.

8. Hur et al., 2022. Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents. Pharmaceuticals,15 (6), 710.

9. Pfanzagl et al., 2022. Histamine via histamine H1 receptor enhances the muscarinicreceptor-induced calcium response to acetylcholine in anenterochromaffin cell model. Clinical & Experimental Pharmacology & Physiology, 49 (10): 1059-1071.

10. Peyraud et al., 2022. Circulating L-Arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors. Annals of oncology, 33 (10): 1041-1051.

下圖為immusmol公司授權(quán)上海起發(fā)實(shí)驗(yàn)試劑有限公司在中國(guó)區(qū)域的代理授權(quán)書(shū)。

immusmol熱賣(mài)產(chǎn)品

作為immusmol在中國(guó)區(qū)域的總代理，上海起發(fā)實(shí)驗(yàn)試劑有限公司將為中國(guó)客戶提供zui全面的immusmol的產(chǎn)品。歡迎大家隨時(shí)聯(lián)系我們?。?！

上海起發(fā)實(shí)驗(yàn)試劑有限公司是進(jìn)口品牌innovrsrch、Abbiotec、ALZET、sysy、biorelevant、mybiosource、ABBEXA、progen、absoluteantibody、moradec、Spherotech、Worthington......，國(guó)產(chǎn)品牌opmbiosciences、elabscience、耐思、碧云天、博奧森、raybiotech、procell、ORIGENE、apexbt、羅恩、奧浦邁、麥克林、成都正能、fn-test、uelandy、天凈沙、杭州博日、君研生物、藍(lán)圖生物、科佰迪、華美、UElandy Inc（試劑）......等300多個(gè)品牌中國(guó)授權(quán)代理，更多請(qǐng)查詢上海起發(fā)實(shí)驗(yàn)試劑有限公司網(wǎng)站。

其他優(yōu)勢(shì)服務(wù)：大訂單國(guó)外談價(jià)格折扣，幫客戶做審批，進(jìn)口報(bào)關(guān)服務(wù)，在采購(gòu)中遇到難買(mǎi)的東西都可以來(lái)問(wèn)我們，不一定從我們這邊走，如果我們沒(méi)有優(yōu)勢(shì)，我們業(yè)務(wù)員也可以告訴您從哪里采購(gòu)。